About Reproductive Solutions
Reproductive Solutions is a company based in Dallas (United States) founded in 2017. Reproductive Solutions has raised $300 thousand across 1 funding round. Reproductive Solutions offers products and services including ProteX At-Home Semen Analysis and NovoSort Sperm Isolation Device. Reproductive Solutions operates in a competitive market with competitors including Memphasys, Cytoswim and ZyMot, among others.
- Headquarter Dallas, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Reproduction Solutions Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$300 K (USD)
in 1 rounds
-
Latest Funding Round
$300 K (USD), Seed
Jul 07, 2020
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Reproductive Solutions
Reproductive Solutions offers a comprehensive portfolio of products and services, including ProteX At-Home Semen Analysis and NovoSort Sperm Isolation Device.
Device for at-home semen collection to protect and assess sperm quality.
In-cup solution for isolating motile sperm for fertility procedures.
Funding Insights of Reproductive Solutions
Reproductive Solutions has successfully raised a total of $300K through 1 strategic funding round. The most recent funding activity was a Seed round of $300 thousand completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $300,000
-
First Round
First Round
(07 Jul 2020)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2020 | Amount | Seed - Reproductive Solutions | Valuation |
investors |
|
Investments & Acquisitions by Reproductive Solutions
Financial Statements - Reproductive Solutions
Reproductive Solutions Comparisons
Competitors of Reproductive Solutions
Reproductive Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Memphasys, Cytoswim and ZyMot, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Reproductive cell separation techniques for assisted reproduction are developed.
|
|
| domain | founded_year | HQ Location |
Sperm selection tools for assisted reproduction are developed.
|
|
| domain | founded_year | HQ Location |
Develops innovative sperm separation devices for medical applications.
|
Frequently Asked Questions about Reproductive Solutions
Reproductive Solutions was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Reproductive Solutions is headquartered in Dallas, United States. It is registered at Dallas, Texas, United States.
Diana Peninger is the current CEO of Reproductive Solutions.
Reproductive Solutions is a funded company, having raised a total of $300K across 1 funding round to date. The company's 1st funding round was a Seed of $300K, raised on Jul 07, 2020.
Developer of advanced sperm collection and processing technologies. It offers solutions for at-home semen analysis and in-clinic sperm processing, improving sperm quality and increasing the chances of successful conception. The companys products are designed to enhance sperm viability during collection, transport, and preparation for various fertility treatments, including IUI, IVF, and ICSI. These technologies aim to simplify the process for both patients and healthcare providers, improving outcomes and reducing stress. The company also provides support and resources for patients and clinics.
Reproductive Solutions offers ProteX At-Home Semen Analysis and NovoSort Sperm Isolation Device.